Alyeska Investment Group

Alyeska Investment Group is a prominent Chicago-based hedge fund founded in 2008 by Anand Parekh, a former portfolio manager at Citadel. The firm specializes in a market-neutral equity strategy, utilizing deep fundamental research to identify investment opportunities across multiple sectors, with a particularly strong focus on healthcare and life sciences. As a significant institutional investor, Alyeska frequently participates in the financing rounds and public equity offerings of emerging biotechnology companies. The firm is known for its disciplined risk management and its role as a sophisticated player in the alternative investment industry. Alyeska manages several billion dollars in assets and maintains a reputation for its expertise in navigating the complexities of the biotech equity markets.